AREDS Plus Omega-3 for AMD

A compilation study from Tufts University, University of Wisconsin, and the EMMES Corporation researched the effects of taking the AREDS supplement plus omega-3 and reducing dGI (dietary glycemic index) on AMD (age-related macular degeneration). The trial spanned 8 years and studied 3,000 eligible AREDS AMD trial participants.

Looking at the risk of advanced AMD, the study found that the AREDS supplement plus higher intakes of omega-3 (DHA and EPA), and reducing dietary glycemic index (dGI) helped reduce progression of the disease.*

Vitamin Health offers Viteyes Omega-3, a once-daily, high potency softgel provides 1,000 mg omega-3 fatty acids – 300 mg eicosapentaenoic (EPA) and 200 mg docasahexaenoic (DHA).

*Jennifer S. L. Tan, MBBS, BE; Jie Jin Wang, MMed, PhD; Victoria Flood, MPH, PhD; Paul Mitchell, MD, PhD. “Dietary Fatty Acids and the 10-Year Incidence of Age-Related Macular Degeneration.” The Blue Mountains Eye Study. Arch Ophthalmol. 2009;127(5):656-665.

Comments are closed.